Exact Sciences
EXAS
#1553
Rank
$11.17 B
Marketcap
$60.37
Share price
-0.63%
Change (1 day)
-6.55%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

P/S ratio for Exact Sciences (EXAS)

P/S ratio as of December 2024 (TTM): 4.15

According to Exact Sciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.48. At the end of 2024 the company had a P/S ratio of 4.53.

P/S ratio history for Exact Sciences from 2002 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.53-15.42%
20235.3526.81%
20224.22-44.82%
20217.65-42.76%
202013.4-14.23%
201915.6-8.92%
201817.1-27.68%
201723.662.27%
201614.6-35.59%
201522.6-98.33%
2014> 1000571.18%
201320223.39%
201216358.2%
201110376.87%
201058.4130.63%
200925.3
2008N/A-100%
200729.886.63%
200616.016.05%
200513.7-32.61%
200420.4-69.71%
200367.4-70.75%
2002230

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.53-63.19%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
7.70 85.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.3324-108.01%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33-43.77%๐Ÿ‡ซ๐Ÿ‡ท France